Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Direct comparison

Expedited vs. Full Board IRB Review

IRB expedited vs. full board review compared: 45 CFR 46.110 eligibility, who can disapprove, timelines, and what triggers a mid-study switch.

Side-by-side comparison

DimensionExpedited ReviewFull Board Review
Who reviewsIRB Chair, or one or more Chair-designated experienced reviewersThe full convened IRB, quorum present (majority of members, including at least one non-scientist)
Risk thresholdNo more than minimal riskGreater than minimal risk, OR minimal risk that does not fit an expedited category
Eligibility basisMust satisfy BOTH the minimal-risk standard AND fit one of OHRP's enumerated expedited categories (45 CFR 46.110 / 21 CFR 56.110)Default pathway for any non-exempt, non-expedited-eligible human subjects research (45 CFR 46.108)
Can it disapprove a study?No -- disapproval is reserved for the convened boardYes -- the only pathway that can disapprove
Typical timelineDays to roughly 1-2 weeks; not tied to a meeting dateWeeks to a month or more, tied to the IRB’s scheduled (commonly monthly) meeting calendar and submission deadlines
Continuing reviewOften exempt from the continuing-review requirement entirely under 45 CFR 46.109(f) (2018 Common Rule revisions)Required at least annually per 45 CFR 46.109(e) for as long as the study needs convened-board review; FDA-regulated research (21 CFR 56.109(f)) has no equivalent exception
Can change mid-studyCan be elevated to full board by a risk-increasing amendment, new safety information, or a reviewer eligibility determinationCan move to expedited only in narrow, defined circumstances (e.g., certain minor changes to previously approved research)

Common questions

FAQ

Can one reviewer disapprove a study under expedited review?+

No. An expedited reviewer can approve or require modifications, but disapproval is reserved exclusively for a convened meeting of the full IRB under 45 CFR 46.108(b).

Who decides whether a study qualifies for expedited review?+

IRB staff typically make an initial screening determination, which the IRB Chair or a designated experienced reviewer confirms when the review begins, checking both the minimal-risk standard and category fit.

Is expedited review the same as exempt research?+

No. Exempt research is excused from most IRB oversight requirements under specific Common Rule categories; expedited research still receives a full substantive IRB review, just by one or a few reviewers instead of the convened board.

Does expedited review mean less scrutiny?+

Not in principle -- the substantive approval standard is the same. What differs is who reviews it and whether disapproval is possible at that level.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →